SOPHIE NGUYEN: Open Payments
NPI 1497017016 · MORROW, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$419 in 22 payments from 12 companies in 2025. Trend: 2023 $464 · 2024 $462 · 2025 $419
Food & beverage: $419
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $71 |
| Sumitomo Pharma America, Inc. | 4 | $64 |
| Novo Nordisk Inc | 3 | $62 |
| Exact Sciences Corporation | 3 | $47 |
| Astellas Pharma US Inc | 1 | $29 |
| Lilly USA, LLC | 2 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| PFIZER INC. | 1 | $21 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $18 |
Products named: GEMTESA, Cologuard Collection Kit, Veozah, Ozempic, MOUNJARO, REXULTI, JARDIANCE, PREVNAR 20.
Industry payments across GA — which companies pay providers there.
